Sartorius CellGenix GmbH is a majority-owned subsidiary of Sartorius Stedim Biotech GmbH based in Freiburg and develops, produces and sells products worldwide for the manufacture of cell and gene therapeutics. At the end of 2024 the company employed 106 people. Sales in North America and most European countries are carried out via the Sartorius group, while customers in parts of Asia were still supplied via distributors and from 2024 are increasingly served by the group's regional sales companies. In the report Sartorius CellGenix is described as a leading supplier of high‑quality cell culture reagents and produces growth factors, cytokines, recombinant cell culture components and serum‑free media in preclinical and GMP quality.
Die Entwicklung, Formulierung, Produktion und der Vertrieb von kritischen Komponenten und Medien in direktem Zusammenhang mit dem Wachstum und der Modifizierung von Zellen für gen- und zelltherapeutische Verfahren.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5317 (as of 24 September 2026)
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5317 (as of 24 September 2026)
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5317 (as of 24 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 5317 (as of 24 September 2026)
bitop Aktiengesellschaft (bitop AG )
Witten · Forschung und Entwicklung im Bereich Biotechnologie
LGC Genomics GmbH
Berlin · Forschung und Entwicklung im Bereich Biotechnologie
Centogene GmbH
Rostock · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Sign in to view detailed salary and cost trends.
